The present invention relates to methods and pharmaceutical compositions for the prevention and treatment of respiratory bacterial infections and more […]

The present invention relates to a method for detecting mycoplasma 16S rDNA 1.5 kilobase fragment amplified quantitative polymerase chain reaction […]

In the present invention, inventors report the characterization of BCLA (Brain Cyst Load-associated Antigen), a protein exclusively expressed during […]

In the present invention, inventors investigate the representation of neutrophil subsets in severe and critical COVID-19 patients based on Intensive […]

Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. The viral genome is 26–32 kilobases in length. In late December […]

Septic shock is the leading cause of death in intensive care units. Previous studies have highlighted the immunosuppressive protein GILZ […]

Tuberculosis (TB), caused by M. tuberculosis infection, continues to be one of the most prevalent infectious diseases worldwide. The WHO has also […]

Escherichia coli O25b-ST131 clone is a worldwide pandemic clone, causing predominantly community-onset antimicrobial-resistant infection. A high […]

Hepatitis E virus (HEV) is the leading cause of enterically transmitted viral hepatitis globally, and is responsible for 20 million infections and […]

Carbapenemase-producing bacteria isolates are increasingly identified throughout the world. Their early detection is becoming a major issue in the […]